Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Roquette announces restructuring post IFF Pharma buyout; WHO, FDA advance regulatory frameworks

    Data Compilation
    #PharmaFlow

    Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

    Stock Recap
    #PipelineProspector

    Menu

    Anaprox, Miranax, Naprelan, Naposin, Antalgin, Feminax Ultra, Naproxen Sodium

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 36Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    04/06/2025 Aurobindo Pharma Limited
    India
    		 M/s. Apitoria Pharma Private Limited WC-0023 Naproxen Sodium Ph.Eur 2022-06-07 2025-06-25 Survey no. 52,53,58,59,61 to 78,127&128, Pydibhimanvaram Village &Sy.No. 1,2,4t09,11,29,30,31&32, Chittivalasa Village,Ranasthalam Mandal, Srikakulam District, AndhraPradesh, India,Pin?532409
    04/06/2025 Divis Laboratories
    India
    		 M/s Divi's Laboratories Limited WC-0030n Naproxen Sodium BP/USP/Ph.Eur 2022-06-03 2025-06-16 UNIT-II, Annavaram (Post), Chippada Village, Bheemunipatnam Mandai, Visakhapatnam-531162, Andhra Pradesh, India